Convergent TP53 loss and evolvability in cancer
Abstract Cancer cell populations evolve by a stepwise process involving natural selection of the fittest variants within a tissue ecosystem context and as modified by therapy. Genomic scrutiny of patient samples reveals an extraordinary diversity of mutational profiles both between patients with sim...
Main Authors: | Marcela Braga Mansur, Mel Greaves |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | BMC Ecology and Evolution |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12862-023-02146-6 |
Similar Items
-
The TP53 fertility network
by: Diego d'Avila Paskulin, et al.
Published: (2012-01-01) -
Case Report: A Novel Pathomechanism in PEComa by the Loss of Heterozygosity of TP53
by: Henriett Butz, et al.
Published: (2022-03-01) -
Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53
by: Stephen L. Abrams, et al.
Published: (2022-02-01) -
Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations
by: Ilay Caliskan, et al.
Published: (2024-03-01) -
Somatic intronic TP53 c.375+5G mutations are a recurrent but under‐recognized mode of TP53 inactivation
by: M Herman Chui, et al.
Published: (2022-01-01)